Wall Street analysts predict that LifePoint Health, Inc. (NASDAQ:LPNT) will post earnings of $0.96 per share for the current fiscal quarter, Zacks reports. Eight analysts have provided estimates for LifePoint Health’s earnings. The highest EPS estimate is $1.02 and the lowest is $0.87. LifePoint Health reported earnings of $0.94 per share in the same quarter last year, which would indicate a positive year over year growth rate of 2.1%. The firm is scheduled to report its next quarterly earnings results on Friday, October 27th.

On average, analysts expect that LifePoint Health will report full-year earnings of $4.06 per share for the current fiscal year, with EPS estimates ranging from $3.99 to $4.15. For the next financial year, analysts forecast that the company will post earnings of $4.46 per share, with EPS estimates ranging from $4.28 to $4.70. Zacks Investment Research’s earnings per share calculations are an average based on a survey of research analysts that cover LifePoint Health.

LifePoint Health (NASDAQ:LPNT) last announced its earnings results on Tuesday, August 1st. The company reported $0.96 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.90 by $0.06. LifePoint Health had a return on equity of 7.40% and a net margin of 2.61%. The business had revenue of $1.59 billion for the quarter, compared to analysts’ expectations of $1.64 billion. During the same period in the prior year, the business posted $0.69 earnings per share. The firm’s revenue was up .2% on a year-over-year basis.

Several equities analysts recently issued reports on the company. BidaskClub lowered LifePoint Health from a “hold” rating to a “sell” rating in a research report on Tuesday, August 1st. Zacks Investment Research upgraded LifePoint Health from a “hold” rating to a “buy” rating and set a $73.00 price target on the stock in a research report on Thursday, July 13th. Royal Bank Of Canada restated a “buy” rating and set a $77.00 price target on shares of LifePoint Health in a research report on Wednesday, July 5th. Leerink Swann upgraded LifePoint Health from a “market perform” rating to an “outperform” rating and raised their price target for the stock from $73.00 to $74.00 in a research report on Tuesday, June 6th. Finally, Morgan Stanley assumed coverage on LifePoint Health in a research report on Tuesday, June 6th. They set an “equal weight” rating and a $65.00 price target on the stock. Three analysts have rated the stock with a sell rating, eight have issued a hold rating and five have given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $66.18.

In other news, Director Richard H. Evans sold 2,000 shares of LifePoint Health stock in a transaction that occurred on Thursday, May 11th. The stock was sold at an average price of $62.88, for a total value of $125,760.00. Following the sale, the director now directly owns 17,718 shares in the company, valued at approximately $1,114,107.84. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Chairman William F. Carpenter III sold 82,347 shares of LifePoint Health stock in a transaction that occurred on Thursday, June 15th. The stock was sold at an average price of $64.15, for a total value of $5,282,560.05. Following the completion of the sale, the chairman now owns 504,535 shares in the company, valued at $32,365,920.25. The disclosure for this sale can be found here. Over the last quarter, insiders sold 102,000 shares of company stock worth $6,556,824. Corporate insiders own 7.28% of the company’s stock.

Large investors have recently added to or reduced their stakes in the stock. BlackRock Inc. raised its stake in LifePoint Health by 11,671.9% in the first quarter. BlackRock Inc. now owns 3,745,824 shares of the company’s stock valued at $245,351,000 after buying an additional 3,714,004 shares in the last quarter. Dimensional Fund Advisors LP raised its stake in LifePoint Health by 0.5% in the first quarter. Dimensional Fund Advisors LP now owns 3,388,830 shares of the company’s stock valued at $221,969,000 after buying an additional 18,327 shares in the last quarter. Vanguard Group Inc. raised its stake in LifePoint Health by 3.8% in the first quarter. Vanguard Group Inc. now owns 3,266,963 shares of the company’s stock valued at $213,986,000 after buying an additional 120,201 shares in the last quarter. Wellington Management Group LLP raised its stake in LifePoint Health by 5.5% in the first quarter. Wellington Management Group LLP now owns 3,257,272 shares of the company’s stock valued at $213,351,000 after buying an additional 168,451 shares in the last quarter. Finally, Alliancebernstein L.P. raised its stake in LifePoint Health by 4.2% in the first quarter. Alliancebernstein L.P. now owns 1,725,943 shares of the company’s stock valued at $113,049,000 after buying an additional 68,886 shares in the last quarter. Institutional investors own 99.27% of the company’s stock.

Shares of LifePoint Health (NASDAQ LPNT) traded up 1.28% during mid-day trading on Tuesday, reaching $59.50. The company had a trading volume of 213,448 shares. LifePoint Health has a 12-month low of $50.60 and a 12-month high of $70.95. The firm has a market capitalization of $2.39 billion, a PE ratio of 13.32 and a beta of 0.86. The stock has a 50 day moving average price of $64.73 and a 200 day moving average price of $62.97.

ILLEGAL ACTIVITY WARNING: This article was first posted by American Banking News and is the sole property of of American Banking News. If you are reading this article on another domain, it was stolen and reposted in violation of US and international copyright & trademark law. The legal version of this article can be read at https://www.americanbankingnews.com/2017/08/08/0-96-earnings-per-share-expected-for-lifepoint-health-inc-nasdaqlpnt-this-quarter.html.

About LifePoint Health

LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.

Get a free copy of the Zacks research report on LifePoint Health (LPNT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for LifePoint Health (NASDAQ:LPNT)

Receive News & Ratings for LifePoint Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.